InvestorsHub Logo
Followers 131
Posts 11471
Boards Moderated 0
Alias Born 01/06/2010

Re: Amatuer17 post# 1015

Friday, 08/11/2017 6:48:14 AM

Friday, August 11, 2017 6:48:14 AM

Post# of 3872
What are your projections? Doesn't the march toward approval largely offset the dilution?

The drugs in the pipeline are getting closer to becoming revenue producers. There will be swings in share price (count on it!), but unless there are trial failures there should be an underlying slow increase in market cap as trials continue.

Buy on weakness is the mantra. In my view, there is weakness right now.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News